Esophageal Multisegmented FCSEMS for Malignant Strictures
- Conditions
- Oesophageal CancerEsophageal Stent Stenosis
- Interventions
- Device: Multisegmented fully covered self-expandable metal stent
- Registration Number
- NCT04415463
- Lead Sponsor
- Radboud University Medical Center
- Brief Summary
Objective: To assess the safety and feasibility of the implementation of the esophageal multisegmented fully covered self-expandable metal stent (SEMS) for the palliation of patients with malignant dysphagia.
Study design: Prospective observational nonrandomized clinical study.
Study population: A total of 30 patients with malignant dysphagia will be included. Sample size calculation does not apply for this type of study.
Intervention: All patients will be treated with the esophageal multisegmented fully covered SEMS.
Primary end points:
* Safety: complications and adverse events during follow-up with special attention to stent migration rates;
* Efficacy: technical success of stent placement.
Secondary end points:
* Recurrent dysphagia including its cause;
* Functional outcome: Ogilvie dysphagia score and WHO performance score (measured at baseline, 2 weeks and every 4 weeks until death/stent removal, or until a maximum of 6 months follow-up);
* Tissue ingrowth or overgrowth (measured endoscopically every endoscopic evaluation during follow-up);
* Pain related to esophageal stent.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 23
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description FC-SEMS Multisegmented fully covered self-expandable metal stent Placement of multisegmented fully covered self-expandable metal stent
- Primary Outcome Measures
Name Time Method Adverse events 6 months Adverse events during follow-up
Technical success of stent placement 1 day Technical success of stent placement
- Secondary Outcome Measures
Name Time Method Recurrent dysphagia 6 months Ogilvie dysphagia score
Functional outcome 6 months WHO performance score
Tissue ingrowth or overgrowth 6 months Pain related to esophageal stent 6 months Measured using the Visual Analogue Scale (VAS)
Trial Locations
- Locations (1)
Radboudumc
🇳🇱Nijmegen, Gelderland, Netherlands